|
Detailed information for selected cell line:
| Cell Line: |
NYUES11; abnormal karyotype-trisomy 14
|
| NIH Registration Number: |
0236
|
| NIH Approval Number: |
NIHhESC-13-0236
|
| Available for Distribution: |
Yes
|
| Provider Restrictions: |
1. A new destination site (e.g., university, research institute) where these hESCs would be shipped may need to be added to the study protocol and approved by the IRB of New York University School of Medicine;
2. These hESCs or their derivatives cannot be used for transplantation into humans.
|
| Additional Information: |
The cell line carries trisomy 14 and is male. Further information about the characteristics of the hESCs is available at chris.hansis@med.nyu.edu or chrhansis@aol.com.
|
| NIH Restrictions: |
(No Additional Restrictions)
|
| Submitting Organization: |
New York University School of Medicine |
| Provider Name: |
Christoph Hansis, MD, PhD
|
| Provider Phone: |
|
| Provider Email: |
chris.hansis@med.nyu.edu;chrhansis@aol.com
|
| Provider URL: |
|
| Approval Date: |
12/23/2013 |
View All Lines Eligible for Use
Go to NIH Form 2890 Login Page
Go to NIH Stem Cell Information Page
| |
NIH Form 2890:
- Login
Page
(Authorization Required)
Contact Us:
- Email questions to:
hescregistry@mail.nih.gov
(Emails that are offensive or unrelated to stem cells will be
deleted.)
|
| |
|
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
